(1)Shu Y J, Weng H, Bao R F, et al. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study[J]. BMC Cancer, 2014, 14(1):566.
(2)Li M, Zhang S, Wang Z, et al. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.[J]. Tumor Biology, 2013, 34(6):3995.
(3)Li M, Zhang Z, Li X, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway[J]. Nature Genetics, 2014, 46(8):872.
(4)Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, BaoRF, Shu YJ, Ding QC, Mu JS, Gu J, Dong P, Liu YB. Evaluationof two inflammation-based prognostic scores in patients withresectable gallbladder carcinoma. Ann Surg Oncol 2014; 21:449-457 [PMID: 24081806 DOI: 10.1245/s10434-013-3292-z]
(5)Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ,Peng ZH. Combined detection tumor markers for diagnosis andprognosis of gallbladder cancer. World J Gastroenterol 2014; 20:4085-4092 [PMID: 24744600 DOI: 10.3748/wjg.v20.i14.4085]
(6)Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factorsinfluencing prognosis in relation to gallbladder cancer. Dig Dis Sci2013; 58: 2455-2462 [PMID: 23695876 DOI: 10.1007/s10620-013-2713-y]
(7)Mcmillan D C. Systemic inflammation, nutritional status and survival in patients with cancer.[J]. Current Opinion in Clinical Nutrition & Metabolic Care, 2009, 12(3):223.
(8)Watanabe H, Okada M, Kaji Y, et al. [New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)][J]. European Journal of Cancer, 2009, 45(2):228-247.
(9)Ni X J, Zhang X L, Ouyang Q W, et al. An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy[J]. Plos One, 2014, 9(11):e111886.
(10)Hu P, Shen H, Wang G, et al. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study.[J]. Plos One, 2014, 9(9):e108062.
(11)Shibutani M, Maeda K, Nagahara H, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer[J]. World journal of gastroenterology, 2015, 21(34):9966.
(12)Porrata L F, Ristow K, Colgan J P, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma.[J]. Haematologica, 2012, 97(2):262.
(13)Li J, Jiang R, Liu W S, et al. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.[J]. Plos One, 2013, 8(12):e83069.
(14)Lin G N, Peng J W, Liu D Y, et al. Increased lymphocyte to monocyte ratio is associated with better prognosis in patients with newly diagnosed metastatic nasopharyngeal carcinoma receiving chemotherapy.[J]. Tumor Biology, 2014, 35(11):10849-10854.
(15)Edge S B, Compton C C. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual, and the Future of TNM[J]. Annals of Surgical Oncology, 2010, 17(6):1471-1474.
(16)Bui J D, Schreiber R D. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?[J]. Current Opinion in Immunology, 2007, 19(2):203-208.
(17)Coussens L M, Werb Z. Inflammation and cancer.[M]// Inflammation and Cancer. Humana Press, 2002:860-867.
(18)Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?[J]. Lancet, 2001, 357(9255):539-545.
(19)Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.[J]. Carcinogenesis, 2009, 30(7):1073-1081.
(20)Pang Q, Zhang L Q, Wang R T, et al. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma[J]. World Journal of Gastroenterology, 2015, 21(21):6675-6683.
(21)Zhang Y, Jiang C, Li J, et al. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma.[J]. Clinical and Translational Oncology, 2015, 17(10):810-818.
(22)Goeppert B, Frauenschuh L, Zucknick M, et al. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.[J]. British Journal of Cancer, 2013, 109(10):2665-2674.
(23)Nakakubo Y, Miyamoto M, Cho Y, et al. Clinical significance of immune cell infiltration within gallbladder cancer[J]. British Journal of Cancer, 2003, 89(9):1736-1742.
(24)Iwase R, Shiba H, Haruki K, et al. Post-operative lymphocyte count may predict the outcome of radical resection for gallbladder carcinoma[J]. Anticancer Research, 2013, 33(8):3439.
(25)Byrne S, Knox M G. TGF-β is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction[J]. Immunology & Cell Biology, 2007, 86(1):92-97.
(26)Condeelis J, Pollard J W. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis[J]. Cell, 2006, 124(2):263-266.
(27)Tsutsui S, Yasuda K, Suzuki K, et al. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.[J]. Oncology Reports, 2005, 14(2):425-31.
(28)Steidl C, Lee T, Shah S P, et al. Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma[J]. New England Journal of Medicine, 2010, 362(10):875.
(29)Roxburgh C S D, Mcmillan D C. Roxburgh CS, McMillan DCRole of systemic inflammatory response in predicting survival with primary operable cancer. Future Oncol 6(1): 149-163[J]. 2010, 6(1):149-163.
(30)Koike Y, Miki C, Okugawa Y, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.[J]. Journal of Surgical Oncology, 2010, 98(7):540-544.
(31)Jagdev S P, Gregory W, Vasudev N S, et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.[J]. British Journal of Cancer, 2010, 103(11):1649-56.